P-Cure

About:

P-Cure is a biotech company that develops a patient-centric proton therapy solution with clinical benefits and financial advantages.

Website: http://www.p-cure.com/

Top Investors: Line Medical Group

Description:

P-Cure is a biotech company that develops a patient-centric proton therapy solution with clinical benefits and financial advantages. P-Cure provides a compact 360-gantry-less adaptive proton therapy system that fits any radiation oncology department's existing infrastructure. P-Cure's integrated solution for simulating, planning, positioning, and treating patients in the seated position will be optimal for delivering the maximum treatment dose to the tumor site while sparing healthy tissues and organs from treatment-related side effects.

Total Funding Amount:

$15M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Jerusalem, Yerushalayim, Israel

Founded Date:

2007-01-01

Contact Email:

info(AT)p-cure.com

Founders:

Michael Marash

Number of Employees:

11-50

Last Funding Date:

2019-07-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai